The Global Intracranial Aneurysms Market is Forecasted to Grow at a Significant CAGR of 9.10% by 2027, Assesses DelveInsight

New York, USA, Nov. 29, 2022 (GLOBE NEWSWIRE) — The Global Intracranial Aneurysms Market is Forecasted to Grow at a Significant CAGR of 9.10% by 2027, Assesses DelveInsight

According to DelveInsight’s assessment of the intracranial aneurysms market report, the increase in the number of cases associated with abnormalities in the blood vessels present in the brain, such as aneurysms, arteriovenous malformations (AVMs) due to the rise in sedentary lifestyle among the population worldwide, and approval and launch of various intracranial aneurysm treatment devices are the factors likely to propel the global intracranial aneurysms market.

DelveInsight’s Intracranial Aneurysms Market Insights report provides the current and forecast market analysis, individual leading intracranial aneurysms companies’ market shares, challenges, intracranial aneurysms market drivers, barriers, and trends, and key intracranial aneurysms companies in the market. 

Key Takeaways from the Intracranial Aneurysms Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global intracranial aneurysms market during the forecast period. 
• Notable intracranial aneurysms companies such as Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION, and several others are currently operating in the intracranial aneurysms market.
• In June 2022, Medtronic Private Limited, a subsidiary of Medtronic plc, announced the launch of PipelineTM Vantage, a CE-marked fourth-generation flow diverter with Shield TechnologyTM for endovascular treatment of brain aneurysms.
• In August 2021, Biomedica Italia’s partnership with Peter Lazic GmbH for the distribution and manufacturing of L-Aneurysm Clip and microsurgery instruments for neurosurgery was extended. The agreement was signed for the next five years.
• Thus, owing to such developments in the market, rapid growth will be observed in the intracranial aneurysms market during the forecast period.

To read more about the latest highlights related to the intracranial aneurysms market, get a snapshot of the key highlights entailed in the Global Intracranial Aneurysms Market Report

Intracranial Aneurysms Overview

An intracranial aneurysm, also known as a cerebral aneurysm, is a brain artery that dilates abnormally due to a weakening of the inner muscular layer of the blood vessel wall. The vessel dilates in a “blister-like” fashion, becoming thin and rupturing without warning. The treatment for intracranial aneurysms primarily consists of two options: surgical clipping and endovascular treatment, which is less invasive than surgical clipping and involves devices such as a flow diverter, an intraluminal flow disrupter, a stent, or coils. 

Intracranial Aneurysms Market Insights

The global Intracranial Aneurysms market is being researched in North America, Europe, Asia-Pacific, and the Rest of the World. North America currently leads the global market in terms of revenue share and is expected to maintain this position throughout the study period. This dominance is due to the target population’s exponentially increasing prevalence in the region. 

Furthermore, strategic business activities and product approval in the region for the expansion of the intracranial aneurysm market would benefit the regional market. Kaneka Corporation, for example, received FDA approval for its new brain aneurysm Embolization coil, i-ED COILTM, in 2020. Furthermore, the company signed an agreement with Asahi Intecc USA, Inc. to expand device sales in the United States beginning in August 2021. Thus, the increase in aneurysm cases and the expansion of the intracranial aneurysms treatment devices market in the region are expected to boost the intracranial aneurysms market.

To know more about why North America is leading the market growth in the intracranial aneurysms market, get a snapshot of the Intracranial Aneurysms Market Outlook 

Intracranial Aneurysms Market Dynamics

The global intracranial aneurysms market is expected to grow significantly due to the increased approval and launch of various technologically advanced intracranial aneurysm treatment products. In addition, rising research and development activities for developing intracranial aneurysm treatment devices and the growing burden of the world’s elderly population are driving the intracranial aneurysm market.

However, the stringent regulatory approval process for intracranial aneurysm treatment devices and device complications will likely hamper intracranial aneurysms market growth.

Additionally, the COVID-19 pandemic has significantly impacted the global healthcare system. The system was transitioned quickly to deal with the pandemic’s burden, which meant that other health issues were unavoidably sidelined. Furthermore, the implementation of lockdowns, social distancing norms, containment measures in several countries, and a halt in various surgeries have slowed the intracranial aneurysm market. According to various surveys and research published in 2021, there were a 22.5% decrease in subarachnoid hemorrhage (SAH) hospitalizations.

Get a sneak peek at the intracranial aneurysms market dynamics @Intracranial Aneurysms Market Dynamics Analysis

Intracranial Aneurysms Market Assessment

• Intracranial Aneurysms Market Segmentation
  • Market Segmentation By Product Type: Surgical Clipping, Embolization Coils, Flow Diverters, Others
  • Market Segmentation By End User: Hospitals And Ambulatory Surgical Centers
  • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the intracranial aneurysms market are set to emerge as the trendsetter explore @Intracranial Aneurysms Companies 

Table of Contents 

Interested in knowing the intracranial aneurysms market by 2027? Click to get a snapshot of the Intracranial Aneurysms Market Trends

Related Reports

Brain Aneurysm Stents Market

Brain Aneurysm Stents Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain aneurysm stents companies, including Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, among others.

Peripheral Aneurysms Market

Peripheral Aneurysm Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key peripheral aneurysms companies, including Medtronic, Abbott, Stryker, among others.

Aortic Aneurysm Stent Grafts Market

Aortic Aneurysm Stent Grafts Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key aortic aneurysm stent grafts companies, including Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech, among others.

Abdominal Aortic Aneurysm Market

Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key abdominal aortic aneurysm companies, including Endologix LLC, Cardinal Health, Cook Medical, among others.

Aneurysmal Subarachnoid Hemorrhage Market

Aneurysmal Subarachnoid Hemorrhage Market Insights, Epidemiology and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key aneurysmal subarachnoid hemorrhage companies, including Idorsia Pharmaceuticals, BIT Pharma GmbH, Akari Therapeutics, among others.

Other Trending Reports

Goitre Market | Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Weight Loss/Weight Management (Obesity) Market | Food Allergy Market | Obsessive-Compulsive Disorder Market | Tumor Ablation Market | Physiotherapy Equipment Market | CAR-T Pipeline Insight | Anti-hypertension Market | Radiofrequency Ablation Devices Market | Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market | Gastro Intestinal Bleeding Market | Trastuzumab Biosimilars Insight | Varicose Veins Market | Germ Cell Tumor Market | Intracardiac Echocardiography Devices Market | India Healthcare Outlook Report | Crows Feet Market Insight | Seborrhoeic Dermatitis Market | Injectable Drug Delivery Devices Market | Structural Heart Devices Market | Substance (Drug) Abuse Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.